Medifast, Inc. (MED) has seen its shares dive 48.9% in the past six months against the industry's growth of 0.6%. This weight management and healthy living product company has also trailed the broader Zacks Consumer Staples sector and the S&P 500's respective growth of 6.4% and 6.5%. Closing the trading session at $18.26 on Wednesday, the stock hovers close to its 52-week low of $17.73. This significant decline in Medifast's stock price can be attributed to several factors that have weighed on the company's ...